Rituxan hycela 1,400 MG-23,400 11.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CZ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,836
Award facts
- Contract value 100% obligated
- $7,836.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $7,836.46 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 11.7ml units. This is a firm fixed price delivery order with an ultimate completion date of December 16, 2025, issued on November 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company has demonstrated significant capability in meeting federal procurement requirements through competitive awards across a diverse portfolio of pharmaceutical products and medical supplies. As a prime contractor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen supplies a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other government healthcare systems worldwide. This specific delivery order for Rituxan Hycela, a biologic immunosuppressant medication, reflects the company's ongoing role in supplying specialized pharmaceutical products to federal military healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F9CZ3?
SPE2DR26F9CZ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9CZ3 worth?
The government has obligated $7,836 on SPE2DR26F9CZ3.
Is contract SPE2DR26F9CZ3 an order under another contract?
Yes. SPE2DR26F9CZ3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CZ3 competed?
The extent of competition for SPE2DR26F9CZ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award